IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
0.7290
-0.0400 (-5.20%)
Nov 20, 2026, 5:29 PM CET
IRLAB Therapeutics AB Revenue
IRLAB Therapeutics AB had revenue of 6.93M SEK in the quarter ending September 30, 2026, a decrease of -63.22%. This brings the company's total for the last twelve months to 67.42M, down -21.20% year-over-year. In the year 2025, IRLAB Therapeutics AB had annual revenue of 57.46M, down -39.28%. That makes IRLAB Therapeutics AB the 39,049th largest company in the world by revenue and 541st in Sweden.
Revenue (ttm)
67.42M
Revenue Growth
-21.20%
P/S Ratio
1.61
Revenue / Employee
2.17M
Employees
28
Market Cap
108.41M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57.46M | -37.17M | -39.28% |
| Dec 31, 2024 | 94.63M | 88.95M | 1,566.57% |
| Dec 31, 2023 | 5.68M | -55.46M | -90.71% |
| Dec 31, 2022 | 61.14M | -146.65M | -70.58% |
| Dec 31, 2021 | 207.78M | - | - |
| Dec 31, 2020 | 0 | - | - |
| Dec 31, 2019 | 26.00K | 8.00K | 44.44% |
| Dec 31, 2018 | 18.00K | -91.00K | -83.49% |
| Dec 31, 2017 | 109.00K | -35.00K | -24.31% |
| Dec 31, 2016 | 144.00K | - | - |
| Dec 31, 2015 | 0 | - | - |
| Dec 31, 2014 | 54.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BioInvent International AB | 39.98M |
| Biovica International AB | 14.93M |
| OncoZenge AB | 5.94M |
| Abera Bioscience AB | 5.66M |
| Xintela AB | 3.03M |
| Simris Group AB (PUBL) | 1.14M |
| Diamyd Medical AB | 477.00K |
| Alzinova AB | 180.00K |
IRLAB Therapeutics AB News
- 9 days ago - IRLAB Therapeutics AB Quarterly report: Q3 2026 - Filings
- 2 months ago - IRLAB Therapeutics AB Quarterly report: Q2 2026 - Filings
- 2 months ago - IRLAB Therapeutics AB Slides: Q2 2026 - Filings
- 6 months ago - IRLAB Therapeutics AB Quarterly report: Q1 2026 - Filings
- 6 months ago - IRLAB Therapeutics AB Slides: Q1 2026 - Filings
- 9 months ago - IRLAB Therapeutics AB Quarterly report: Q4 2025 - Filings
- 9 months ago - IRLAB Therapeutics AB Slides: Q4 2025 - Filings
- 9 months ago - IRLAB Therapeutics AB Annual report: Q4 2025 - Filings